These findings support the hypothesis that IL-21/IL-21R signaling contributes to a better response to chemotherapy and is associated with higher CR rates in patients with AML and support the notion that IL-21 could also be applied to other combination approaches in the field of AML. Here, IL21 is linked to acute myeloid leukemia.